carbapenems has been researched along with cs 834 in 13 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (cs 834) | Trials (cs 834) | Recent Studies (post-2010) (cs 834) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 13 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, R; Hisaoka, M; Kawamoto, I; Miyauchi, M; Yasuda, H | 1 |
| Kanno, O; Kawamoto, I; Miyauchi, M | 1 |
| Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H | 1 |
| Hisaoka, M; Ikeda, Y; Kondo, K; Naganuma, H; Nakashima, M; Nishino, H; Tajima, M; Umemura, K | 1 |
| Fukuoka, T; Harasaki, T; Iwata, M; Kamai, Y; Kawada, H; Kitayama, A; Koga, T; Kubota, M; Kuwahara, S; Ohya, S; Yasuda, H | 1 |
| Domon, H; Furuya, N; Ishii, K; Matsumoto, T; Miyazaki, S; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
| Nishino, T; Oh, T; Otsuki, M; Ou, T; Sakagawa, E | 1 |
| Kato, H; Kato, N; Tanaka, K; Watanabe, K | 1 |
| Mori, M; Oida, S | 1 |
| Kaneko, T; Kato, N; Liu, CX; Sakata, T; Watanabe, K | 1 |
| Fukuhara, H; Hata, T; Ito, S; Kawamoto, I; Kobayashi, K | 1 |
| Fukuhara, H; Hata, T; Kawamoto, I; Kobayashi, K; Ohashi, Y; Sekine, A; Uekusa, H | 1 |
| Fukuhara, H; Hata, T; Kobayashi, K; Ohashi, Y | 1 |
13 other study(ies) available for carbapenems and cs 834
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834.
Topics: Administration, Oral; Animals; Carbapenems; Cilastatin; Dogs; Drug Interactions; Gram-Positive Bacteria; Injections, Intravenous; Mice; Microbial Sensitivity Tests; Protease Inhibitors; Structure-Activity Relationship | 1997 |
A novel oral carbapenem CS-834: chemical stability of pivaloyloxymethyl esters of carbapenems and cephalosporins in phosphate buffer solution.
Topics: Carbapenems; Drug Stability; Esters; Structure-Activity Relationship | 1997 |
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins | 1997 |
Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers.
Topics: Administration, Oral; Adult; Blood Proteins; Carbapenems; Carnitine; Drug Administration Schedule; Humans; Male; Middle Aged; Pilot Projects; Prodrugs; Protein Binding | 1997 |
Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice.
Topics: Animals; Carbapenems; Disease Models, Animal; Drug Evaluation, Preclinical; Lung; Male; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Prodrugs; Streptococcus pneumoniae; Treatment Outcome | 1998 |
In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.
Topics: Animals; Carbapenems; Cilastatin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Prodrugs; Protease Inhibitors; Sepsis | 1998 |
In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem.
Topics: Administration, Oral; Animals; Bacteria; Bacterial Infections; Bacterial Proteins; Carbapenems; Carrier Proteins; Colony Count, Microbial; Drug Resistance, Microbial; Escherichia coli; Hexosyltransferases; Male; Mice; Microbial Sensitivity Tests; Microscopy, Interference; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Prodrugs; Protein Binding | 1998 |
In vitro activity of R-95867, the active metabolite of a new oral carbapenem, CS-834, against anaerobic bacteria.
Topics: Bacteria, Anaerobic; beta-Lactamases; Carbapenems; Culture Media; Drug Resistance, Microbial; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Prodrugs | 2000 |
A short-step synthesis of orally active carbapenem antibiotic CS-834.
Topics: Carbapenems; Indicators and Reagents; Magnetic Resonance Spectroscopy; Prodrugs | 2000 |
Impact of a new quinolone, DU-6859a, and two oral carbapenems, CS-834 and L-084, on the rat and mouse caecal microflora.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Carbapenems; Cecum; Fluoroquinolones; Male; Mice; Prodrugs; Rats; Rats, Wistar | 2000 |
Crystal structure of a 1beta-methylcarbapenem antibiotic, pivaloyloxymethyl (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[[(R)-5-oxopyrrolidin-3-yl]thio]-1-carbapen-2-em-3-carboxylate, CS-834 dihydrate.
Topics: Carbapenems; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Prodrugs; Stereoisomerism; Thermodynamics | 2001 |
Physicochemical analyses of phase transition and dehydration processes of a new oral 1beta-methylcarbapenem antibiotic agent, CS-834.
Topics: Administration, Oral; Calorimetry, Differential Scanning; Carbapenems; Desiccation; Drug Design; Drug Stability; Spectroscopy, Fourier Transform Infrared; Titrimetry; X-Ray Diffraction | 2002 |
In situ observation of the four-step dehydration process of the 1 beta-methylcarbapenem antibiotic CS-834 crystal by X-rays.
Topics: Anti-Bacterial Agents; Carbapenems; Desiccation; X-Ray Diffraction | 2003 |